Investor alert: shareholder class action lawsuit filed against regeneron pharmaceuticals, inc. (nasdaq: regn); dicello levitt llp encourages investors with losses to discuss their options with counsel

San diego, jan. 10, 2025 (globe newswire) -- a class action lawsuit has been filed on behalf of all persons and entities who purchased or otherwise acquired regeneron pharmaceuticals, inc. (nasdaq: regn) (“regeneron” or the “company”) common stock between november 2, 2023 and october 30, 2024 (the “class period”), charging the company and certain of its current and former senior executives with violations of the federal securities laws (collectively, “defendants”).
REGN Ratings Summary
REGN Quant Ranking